ALLR insider trading

NasdaqCM Healthcare

Allarity Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
16
Last 90 days
2
Buys / sells
0% / 0%
Market cap
$18.01M

About Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2 clinical trial in patients with advanced and recurrent ovarian cancer. The company also develops stenoparib- DRP, a companion diagnostic product used in select patients for stenoparib treatment. Allarity Therapeutics, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Company website: www.allarity.com

ALLR insider activity at a glance

FilingIQ tracks 16 insider transactions for ALLR in filings since Oct 1, 2024. The most recent transaction is dated Sep 30, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

Latest ALLR Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for ALLR?
FilingIQ tracks 16 Form 4 insider transactions for ALLR (Allarity Therapeutics, Inc.), covering filings from Oct 1, 2024 onwards. 2 of those are dated within the last 90 days.
Are ALLR insiders net buyers or net sellers?
Across the full Form 4 history for ALLR, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ALLR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is ALLR in?
Allarity Therapeutics, Inc. (ALLR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.01M.

Methodology & sources

Every ALLR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.